Med-life discoveries

About:

Med-Life Discoveries is a developer of novel synthetic plasmalogens and plasmalogen precursors as treatments for biogenesis disorders.

Website: https://med-life.ca/

Top Investors: Michael J. Fox Foundation, Golden Opportunities Fund

Description:

Med-Life Discoveries is a biopharmaceutical company that develops synthetic plasmalogens and plasmalogen precursors for the treatment of diseases. They provide metabolic precursor products that contain the chemical bonds that the peroxisomal enzymes normally produce to treat Alzheimer's disease and Parkinson's disease. Their objective is to build on decades of research revealing that metabolic abnormalities occur before the development of disease.

Total Funding Amount:

$5.25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saskatoon, Saskatchewan, Canada

Founded Date:

2015-01-01

Contact Email:

info(AT)med-life.ca

Founders:

Number of Employees:

1-10

Last Funding Date:

2020-07-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai